131 related articles for article (PubMed ID: 7659273)
1. Fucoidin, a polysaccharide inhibiting leukocyte rolling, attenuates inflammatory responses in experimental pneumococcal meningitis in rats.
Angstwurm K; Weber JR; Segert A; Bürger W; Weih M; Freyer D; Einhäupl KM; Dirnagl U
Neurosci Lett; 1995 May; 191(1-2):1-4. PubMed ID: 7659273
[TBL] [Abstract][Full Text] [Related]
2. Experimental pneumococcal meningitis: cerebrovascular alterations, brain edema, and meningeal inflammation are linked to the production of nitric oxide.
Koedel U; Bernatowicz A; Paul R; Frei K; Fontana A; Pfister HW
Ann Neurol; 1995 Mar; 37(3):313-23. PubMed ID: 7535035
[TBL] [Abstract][Full Text] [Related]
3. Blocking of leukocyte accumulation in the cerebrospinal fluid augments bacteremia and increases lethality in experimental pneumococcal meningitis.
Brandt CT; Lundgren JD; Frimodt-Møller N; Christensen T; Benfield T; Espersen F; Hougaard DM; Ostergaard C
J Neuroimmunol; 2005 Sep; 166(1-2):126-31. PubMed ID: 15982752
[TBL] [Abstract][Full Text] [Related]
4. Methylprednisolone attenuates inflammation, increase of brain water content and intracranial pressure, but does not influence cerebral blood flow changes in experimental pneumococcal meningitis.
Koedel U; Pfister HW; Tomasz A
Brain Res; 1994 Apr; 644(1):25-31. PubMed ID: 8032946
[TBL] [Abstract][Full Text] [Related]
5. Mannitol, but not allopurinol, modulates changes in cerebral blood flow, intracranial pressure, and brain water content during pneumococcal meningitis in the rat.
Lorenzl S; Koedel U; Pfister HW
Crit Care Med; 1996 Nov; 24(11):1874-80. PubMed ID: 8917039
[TBL] [Abstract][Full Text] [Related]
6. Heparin inhibits leukocyte rolling in pial vessels and attenuates inflammatory changes in a rat model of experimental bacterial meningitis.
Weber JR; Angstwurm K; Rosenkranz T; Lindauer U; Freyer D; Bürger W; Busch C; Einhäupl KM; Dirnagl U
J Cereb Blood Flow Metab; 1997 Nov; 17(11):1221-9. PubMed ID: 9390654
[TBL] [Abstract][Full Text] [Related]
7. Systemically (but not intrathecally) administered IL-10 attenuates pathophysiologic alterations in experimental pneumococcal meningitis.
Koedel U; Bernatowicz A; Frei K; Fontana A; Pfister HW
J Immunol; 1996 Dec; 157(11):5185-91. PubMed ID: 8943431
[TBL] [Abstract][Full Text] [Related]
8. Effects of polysaccharide fucoidin on cerebrospinal fluid interleukin-1 and tumor necrosis factor alpha in pneumococcal meningitis in the rabbit.
Granert C; Raud J; Waage A; Lindquist L
Infect Immun; 1999 May; 67(5):2071-4. PubMed ID: 10225856
[TBL] [Abstract][Full Text] [Related]
9. Protective effect of a 21-aminosteroid during experimental pneumococcal meningitis.
Lorenzl S; Koedel U; Frei K; Bernatowicz A; Fontana A; Pfister HW
J Infect Dis; 1995 Jul; 172(1):113-8. PubMed ID: 7797900
[TBL] [Abstract][Full Text] [Related]
10. The polysaccharide fucoidin inhibits the antibiotic-induced inflammatory cascade in experimental pneumococcal meningitis.
Granert C; Raud J; Lindquist L
Clin Diagn Lab Immunol; 1998 May; 5(3):322-4. PubMed ID: 9605985
[TBL] [Abstract][Full Text] [Related]
11. Effect of catalase on regional cerebral blood flow and brain edema during the early phase of experimental pneumococcal meningitis.
Pfister HW; Ködel U; Dirnagl U; Haberl RL; Ruckdeschel G; Einhäupl KM
J Infect Dis; 1992 Dec; 166(6):1442-5. PubMed ID: 1431262
[TBL] [Abstract][Full Text] [Related]
12. Antioxidants attenuate microvascular changes in the early phase of experimental pneumococcal meningitis in rats.
Pfister HW; Koedel U; Lorenzl S; Tomasz A
Stroke; 1992 Dec; 23(12):1798-804. PubMed ID: 1448831
[TBL] [Abstract][Full Text] [Related]
13. Tumour necrosis factor alpha induces only minor inflammatory changes in the central nervous system, but augments experimental meningitis.
Angstwurm K; Freyer D; Dirnagl U; Hanisch UK; Schumann RR; Einhäupl KM; Weber JR
Neuroscience; 1998 Sep; 86(2):627-34. PubMed ID: 9881875
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of leukocyte rolling with polysaccharide fucoidin prevents pleocytosis in experimental meningitis in the rabbit.
Granert C; Raud J; Xie X; Lindquist L; Lindbom L
J Clin Invest; 1994 Mar; 93(3):929-36. PubMed ID: 7510720
[TBL] [Abstract][Full Text] [Related]
15. Effect of the bradykinin B2 receptor antagonist Hoe140 in experimental pneumococcal meningitis in the rat.
Lorenzl S; Ködel U; Frei K; Pfister HW
Eur J Pharmacol; 1996 Jul; 308(3):335-41. PubMed ID: 8858309
[TBL] [Abstract][Full Text] [Related]
16. Induced hypothermia in experimental pneumococcal meningitis.
Angstwurm K; Reuss S; Freyer D; Arnold G; Dirnagl U; Schumann RR; Weber JR
J Cereb Blood Flow Metab; 2000 May; 20(5):834-8. PubMed ID: 10826534
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of leukocyte entry into the brain by the selectin blocker fucoidin decreases interleukin-1 (IL-1) levels but increases IL-8 levels in cerebrospinal fluid during experimental pneumococcal meningitis in rabbits.
Ostergaard C; Yieng-Kow RV; Benfield T; Frimodt-Møller N; Espersen F; Lundgren JD
Infect Immun; 2000 Jun; 68(6):3153-7. PubMed ID: 10816457
[TBL] [Abstract][Full Text] [Related]
18. Experimental studies of pneumococcal meningitis.
Brandt CT
Dan Med Bull; 2010 Jan; 57(1):B4119. PubMed ID: 20175949
[TBL] [Abstract][Full Text] [Related]
19. Triptans reduce the inflammatory response in bacterial meningitis.
Hoffmann O; Keilwerth N; Bille MB; Reuter U; Angstwurm K; Schumann RR; Dirnagl U; Weber JR
J Cereb Blood Flow Metab; 2002 Aug; 22(8):988-96. PubMed ID: 12172384
[TBL] [Abstract][Full Text] [Related]
20. Tyrosine kinase inhibition reduces inflammation in the acute stage of experimental pneumococcal meningitis.
Angstwurm K; Hanisch UK; Gassemi T; Bille MB; Prinz M; Dirnagl U; Kettenmann H; Weber JR
Infect Immun; 2004 Jun; 72(6):3294-8. PubMed ID: 15155632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
